Virtu KCG Holdings’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Virtu KCG Holdings’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-29,160	Closed	-$20K	–	4131
2015 Q4	$20K	Buy	29,160 +18,813	+182%	+$19.4K	﹤0.01%	3312
2015 Q3	$13K	Sell	10,347 -12,960	-56%	-$15.1K	﹤0.01%	3209
2015 Q2	$25K	Buy	+23,307	New	+$35K	﹤0.01%	3173
2015 Q1	–	Sell	-22,449	Closed	-$33K	–	4319
2014 Q4	$33K	Sell	22,449 -2,929	-12%	-$5.23K	﹤0.01%	3524
2014 Q3	$60K	Buy	+25,378	New	+$96.9K	﹤0.01%	3314
2014 Q2	–	Sell	-39,026	Closed	-$172K	–	4323
2014 Q1	$172K	Buy	39,026 +26,058	+201%	+$134K	﹤0.01%	3058
2013 Q4	$61K	Buy	12,968 +2,173	+20%	+$10.7K	﹤0.01%	3561
2013 Q3	$55K	Buy	+10,795	New	+$50.8K	﹤0.01%	3492

Other funds holding ALXA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings's ALXA Position: Q1 2016 in Review

Virtu KCG Holdings sold out of Alexza Pharmaceuticals Inc (ALXA) in Q1 2016, closing a stake of 29,160 shares — an estimated $20K sold.

Virtu KCG Holdings first reported a position in ALXA in Q3 2013 and held it in 8 quarters. The position peaked at $172K in Q1 2014. 25 funds tracked by Wall St. Rank hold ALXA as of Q1 2016.

Virtu KCG Holdings reported no remaining Alexza Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Virtu KCG Holdings sold 29,160 Alexza Pharmaceuticals Inc shares in Q1 2016, an estimated $20K.
Virtu KCG Holdings first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
Virtu KCG Holdings's Alexza Pharmaceuticals Inc position peaked at $172K in Q1 2014.
25 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q1 2016.

Based on Virtu KCG Holdings's 13F filing for Q1 2016, filed 13 May 2016.